Gemifloxacin (Compound)

Synonyms:Gemifloxacin, Gemifioxacin, 175463-14-6, Gemifloxacin mesilate, Gemifloxacin [INN], Gemifloxacin (INN), LB-20304, CHEMBL430, CHEBI:101853, SB-265805, (Z)-7-(3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid, 7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, Factiv (TN), LB 20304, SR-05000001958, 7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid, HSDB 8027, 7-(3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, BSPBio_002308, SCHEMBL136633, DTXSID3048495, SCHEMBL13414391, BDBM50178917, AKOS015907681, AM84619, DB01155, NCGC00178711-01, NCGC00178711-06, 1,8-Naphthyridine-3-carboxylic acid, 7-(3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, 204519-64-2, 7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, SBI-0206906.P001, D08012, AB01563334_01, 463G146, A812090, SR-05000001958-2, BRD-A40787240-066-02-0, BRD-A40787240-066-03-8, (S,Z)-7-(3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, 1,4-Dihydro-1-cyclopropyl-4-oxo-6-fluoro-7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidine-1-yl]-1,8-naphthyridine-3-carboxylic acid, 1,4-Dihydro-6-fluoro-1-cyclopropyl-4-oxo-7-[(3E)-4-(aminomethyl)-3-(methoxyimino)pyrrolidine-1-yl]-1,8-naphthyridine-3-carboxylic acid, 1,8-Naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;Gemifloxacin, 7-{3-Aminomethyl-4-[(Z)-methoxyimino]-pyrrolidin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, Gemifloxacin; 7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-[1, 8]naphthyridine-3-carboxylic acid; 210353-56-3

Pubchem:PUBCHEM:9571107

Id:9571107

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Gemifloxacin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Gemifloxacin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Gemifloxacin.

Results found

Linked to

	Label	Description
	BRD-A40787240-066-03-8 Substance (Entity type)	A Substance
	DCSTRUCT ID 01286 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01286; PubChem_CID:9571107, FILE=drugcentral_drug_01286.json)
	gemifloxacin positively regulates TGFBR2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Epirizole in similarity relationship with gemifloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	gemifloxacin positively regulates PON3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tasisulam in similarity relationship with gemifloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	gemifloxacin positively regulates PBX3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	gemifloxacin negatively regulates ADIRF Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	reboxetine in similarity relationship with gemifloxacin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	gemifloxacin negatively regulates CXCL14 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS